Background: Insulin resistance plays a determinant role in the development of metabolic syndrome in adolescents. The objective of the present study was to determine the influence of factors commonly associated with insulin resistance in a sample of adolescents. Methods: This cross-sectional study included 976 adolescents from southeast Spain. Anthropometric and biochemical measurements were performed, and insulin resistance was assessed using the homeostasis model assessmentinsulin resistance (HOMA-IR). Results: Subjects with abnormal HOMA-IR values had significantly higher body mass index (BMI), body fat content, waist circumference, and systolic blood pressure (BP) than those with normal values. Furthermore, levels of glucose, insulin, glycosylated hemoglobin, total cholesterol, triglycerides, low-density lipoprotein-cholesterol, homocysteine, nonesterified fatty acids, and ceruloplasmin were higher in subjects with abnormal HOMA-IR values. Multivariate logistic regression analysis showed the highest odds ratio (OR) for BMI and that combinations of BMI with body fat content or systolic BP can increase the risk of insulin resistance 7-fold. Discussion: Anthropometric indicators have different levels of influence on the risk of insulin resistance in adolescents, and a combination of two of these indicators is enough to increase the risk 7-fold. Since the highest OR was observed for BMI, the greatest effort should be directed to reducing this parameter in adolescents. An adequate understanding by nursing personnel of factors associated with insulin resistance is a key factor in the prevention of this pathophysiological condition and its complications in adolescents.
Insulin resistance is a multifactorial process that is established when the amounts of insulin produced physiologically lose the ability to regulate the metabolism of carbohydrates, lipids, and proteins. In general, insulin resistance comprises a decrease in glucose transport induced by the hormone in adipocytes and skeletal muscle, an increase in hepatic glucose output, and alterations in lipid metabolism in adipose and liver tissues (Aguilar Cordero et al., 2010) .
The worldwide proliferation of obesity in the adolescent population is responsible for a corresponding increase in insulin resistance among young people in the developed countries (Chung et al., 2013; Lin et al., 2015) . The excess energy associated with obesity may result in hyperplasia and hypertrophy of adipocytes, leading to oxidative stress. This oxidative stress of adipocytes induces a chronic low-level inflammation in adipose tissue and the production of adipokines, nonesterified fatty acids (NEFA), and inflammatory mediators. This inflammation, in turn, is related to insulin resistance and impaired insulin secretion by the pancreatic b cells. Finally, this process causes dysregulation of glucose homeostasis and development of type 2 diabetes mellitus (T2DM; Van der Aa, Fazeli Farsani, Knibbe, De Boer, & Van der Vorst, 2015) . In addition, studies have suggested that subjects with abnormal homeostasis model assessment-insulin resistance (HOMA-IR) values often show elevated levels of homocysteine, NEFA, and ceruloplasmin, which might constitute an additional risk factor for the premature development of cardiovascular pathology (Zulet, Puchau, Navarro, Marti, & Martinez, 2007) .
It is a widely accepted hypothesis that obesity and insulin resistance are the main factors in the etiology of the metabolic syndrome (MetS), a group of risk factors that, when occurring together, increase the risk of cardiovascular disease and T2DM (Cerezo, Segura, Praga, & Ruilope, 2013) .
Studies carried out to date have used differing criteria to define the MetS in adolescents (Cook, Weitzman, Auinger, Nguyen, & Dietz, 2003; Cruz et al., 2004; De Ferranti et al., 2004; McGillis Bindler, Massey, Shultz, Mills, & Short, 2007; Weiss et al., 2004) . In 2007, the International Diabetes Federation published a set of guidelines for the diagnosis of MetS in children and adolescents that established a simple unified definition (Zimmet et al., 2007) . According to this definition, the identification of MetS in adolescents is based on a waist circumference (WC) of 94 cm or more in males and 80 cm or more in females in combination with other risk factors, such as fasting glucose levels of 100-125 mg/dl, triglyceride levels of least 150 mg/dl, and high-density lipoprotein (HDL)-cholesterol levels lower than 40 mg/dl in males and 50 mg/dl in females, along with a blood pressure (BP) of 130/85 mmHg. Mills et al. (2004) studied a population of 1,865 children and adolescents, 6-18 years of age, over a period of 6 years and showed that insulin resistance was more frequent in those children who subsequently developed MetS, which seems to indicate that insulin resistance precedes the appearance of MetS in childhood. Cruz et al. (2004) analyzed the role of insulin resistance in the development of MetS in obese children of Hispanic descent and reported that sensitivity to insulin was 62% lower among those who had MetS. Furthermore, the authors concluded that insulin sensitivity was independently and negatively related to triglyceride concentrations and BP levels and positively related to levels of HDL-C. These results suggest that the effects of adiposity on dyslipidemia and BP are mediated by insulin resistance.
Taken together, these findings seem to indicate that an initial state of obesity and subsequent insulin resistance both have an important role in the development of MetS. Nevertheless, in obese subjects, insulin resistance seems to play a larger role in the development of MetS than the degree of obesity (Rodrigues, Abreu, Resende, Goncalves, & Gouvea, 2013) . Researchers have generally assumed that intra-abdominal (or visceral) fat accumulation is a phenomenon associated mainly with adulthood. However, subcutaneous adiposity at the waist is a more significant predictor of MetS traits in children and adolescents than it is in adults (Ali et al., 2014) . As a consequence, an increasing number of studies are showing that WC is the best measure for identifying children with insulin resistance and hence those most at risk for MetS (Esmaillzadeh, Mirmiran, Azadbakht, Amiri, & Azizi, 2006; Hirschler, Aranda, Calcagno, Maccalini, & Jadzinsky, 2005; Moreno et al., 2002) .Yet, it remains to be definitively demonstrated whether WC measurement alone is sufficient to identify those children at greatest risk for obesity-related insulin resistance.
Therefore, the purpose of this study was to determine the level of influence of body mass index (BMI), WC, body fat content, and BP on the development of insulin resistance in adolescents in order to establish which is the most prominent. Findings will help researchers and health-care professionals to develop preventive strategies that reduce adolescents' risk of developing MetS.
Method

Design and Setting
We carried out this cross-sectional study in the province of Granada in southeast Spain. To obtain a representative sample, we performed a demographic analysis in order to characterize the population of adolescents between the ages of 10 and 15. According to the municipal census of 2008, the population of adolescents of this age was 49,359, of which 24,055 (48.7%) were boys and 25,304 (51.3%) were girls. Based on these data and assuming an error of 3%, we decided that our sample size would be 976 adolescents (519 females and 457 males), 10-15 years of age, all of Spanish origin, drawn from the sixth grade of primary school to the third year of secondary school. The subjects attended 18 schools in the province of Granada. Among the 18 selected schools, we randomly selected two classes per grade from which to invite participants. The participants had similar socioeconomic statuses.
The Board of Education of the Andalusian Regional Government (Granada Delegation) approved the study, and the school directors authorized it as well. The Ethics Committee of the University of Granada (EC-47851) also approved the study, including the model of informed consent. Parents or guardians explicitly authorized their children's participation in the study by written informed consent. E.G.-J., member of the research team, recorded and protected informed consents, and they remain under his custody. An important condition for inclusion was that participants had to be healthy and not have any type of endocrine dysfunction, physical disorder, or infectious process. We performed this research in strict compliance with the international code of medical ethics established by the World Medical Association and the Declaration of Helsinki.
Measures
Anthropometric measurements. Each participant underwent a complete anthropometric evaluation performed according to the recommendations of the European Pediatric Association (Body Composition Analysis Protocol). The variables assessed were weight, height, and BMI. We performed the anthropometric measurements in the morning after a 12-hr fast and a 24-hr abstention from exercise. We measured body weight (kg) twice (with participants wearing no shoes and in light clothes) using a self-calibrating Seca 1 861 class (III) digital floor scale (Saint Paul, USA) with a precision of up to 100 g. We measured height with a Seca 214* portable stadiometer, asking participants to remove their shoes and stand erect with their backs, buttocks, and heels in continuous contact with the vertical height rod of the stadiometer and head oriented in the Frankfurt plane. We then placed the horizontal headpiece on top of the participants' heads to measure their height. We took height measurements twice to the nearest 0.5 cm. We used the average of the two values for weight and height in the analysis. We calculated BMI as weight divided by height squared (kg/m 2 ). The same trained research assistant performed all the measurements. We defined overweight and obesity, according to the international standards established by Cole, Bellizzi, Flegal, and Dietz (2000) , as values above the 85th and 95th percentiles, respectively, for BMI for age and sex. We also evaluated the triceps, biceps, subscapular, and suprailiac skinfolds with a Holtain 1 skinfold caliper (Saint Paul, USA), which has a precision of 0.1-0.2 mm and used these measurements to calculate the percentage of body fat. The first step in determining percentage of body fat was to calculate body density using Brook's equation (Brook, 1971) :
After determining body density, we used Siri's (1961) equation to calculate body fat percentage: body fat percentage ¼ [(4.95/density) À 4.5] Â 100. We measured the WC of participants. We measured WC with a Seca automatic roll-up measuring tape (precision of 1 mm) using the horizontal plane midway between the lowest rib and the upper border of the iliac crest at the end of a normal inspiration/expiration. We measured hip circumference at the maximum extension of the buttocks as viewed from the right side.
BP determination. We measured BP levels using a previously calibrated aneroid sphygmomanometer and a Littmann 1 stethoscope (Saint Paul, USA). We took all measurements using the right arm after each participant had rested for at least 15 min in a sitting position. We recorded the average of two readings obtained at a minimum of 5 min apart. Systolic BP was based on Korotkoff Phase I and diastolic BP was based on Phase V. Systolic BP ! 130 and/or diastolic BP ! 85 mmHg were regarded as a risk factor of MetS.
Serum Biochemical Analysis
At 8:00 a.m. after participants had fasted for 12 hr overnight, we extracted 10 ml of blood by venipuncture in the antecubital fossa of the right arm with a disposable vacuum blood collection tube. Within 4 hr after the extraction, we centrifuged the samples at 3,500 rpm for 15 min (Z400 K, Hermle, Wehingen, Germany) to separate the red blood cells. We froze the serum at À80 C for subsequent analysis.
Immediately after collection and before centrifugation, however, we measured glucose concentration using an enzymatic colorimetric method (glucose oxidase-phenolaminophenazone [GOD-PAP] method, Human Diagnostics, Germany) as well as the concentrations of HDL-C, total cholesterol, and triglycerides by means of enzymatic colorimetric methods using an Olympus analyzer. Low-density lipoprotein-cholesterol (LDL-C) was estimated using the Friedewald equation ð½LDL À C ¼ ½Total cholesterol À ½HDL À C À ð½TG=5Þ
, where TG ¼ concentration of triglycerides. The remaining analyses were conducted using the samples that had been frozen. We determined serum levels of homocysteine (mmol/L) with the enzymatic assay. For the determination of ceruloplasmin levels, however, we used an immunoturbidometric assay (Architect ci8200, Abbott, Abbott Park, IL), which had an intra-assay variation coefficient of 3.7%, an inter-assay precision of up to 4%, and a reference of 20-60 mg/dl. Serum insulin was determined by radioimmunoanalysis (Insulin Kit, DPC, Los Angeles, CA). We measured the glycosylated hemoglobin (HbA1c) by high-performance liquid chromatography using an automated analyzer certified by the National Glycohemoglobin Standardization Program (model HLC-723 G7, Tosoh, Tokyo, Japan; intra-assay coefficient of variation <0.8%, interassay coefficient of variation <0.5%) and standardized the levels according to the Diabetes Control and Complications Trial.
We quantified insulin resistance (IR) using HOMA (Matthews et al., 1985) by applying the following formula: fasting glucose (mmol/L) Â fasting insulin (mU/L)/22.5. We divided participants into two groups based on their HOMA-IR, calculating the HOMA-IR cutoff point, using its receiver operating characteristic curve, as 3.83 with a sensitivity of 80.5% and a specificity of 79.8%. Therefore, HOMA-IR > 3.83 was regarded as abnormal and HOMA-IR < 3.83 as normal.
Statistical Analysis
We compared the mean values of continuous variables using Student's t-test and the categorical variables between abnormal and normal HOMA-IR groups using w 2 . We assessed the level of influence of BMI, body fat percentage, WC, and systolic BP on IR by calculating the odds ratio (OR) and the 95% confidence intervals (CIs) for the abnormal HOMA-IR group in comparison to the normal group. We used a multivariate logistic regression model for this purpose because we found these factors to be significant in the univariate model. After adjusting the risk factors, we combined the effects of the BMI, WC, and systolic BP to examine the combined risk effect for HOMA-IR abnormality. Two-sided p values < .05 were regarded as statistically significant. We analyzed data using SPSS software for Linux 155, Version 21.0 (IBM Corp, Armonk, NY, USA). Table 1 lists the physical characteristics of the participants, who were divided into two groups: (i) 28.1% had abnormal HOMA-IR values (> 3.83) and (ii) 71.9% had normal HOMA-IR values (< 3.83). BMI, body fat percentage, WC, and systolic and diastolic BP values were significantly higher in participants with abnormal HOMA-IR values compared to those with normal values (p < .001). However, we found no significant correlation between HOMA-IR group and age (p ¼ .202) or gender (p ¼ .510). Table 2 shows the serum biochemical data for the 976 participants with either normal or abnormal HOMA-IR values. The levels of glucose, insulin, HBA1c, total cholesterol, triglycerides, LDL-C, homocysteine, NEFA, and ceruloplasmin were significantly higher (p < .001) in participants with abnormal HOMA-IR values. It is noteworthy that, besides the more common parameters such as glucose, insulin, HBA1c, triglycerides, NEFA, total cholesterol, LDL-C, and HDL-C, less common parameters like homocysteine and ceruloplasmin differed between the two groups as well.
Results
As shown in Table 3 , the crude ORs of HOMA-IR abnormality were 38.71, 6.89, 9.27, and 4.78, respectively, for BMI, body fat content, WC, and systolic BP, with all of them showing statistical significance. After adjusting for gender, we found that the ORs were similar to the crude OR values. Likewise, after adjustment for gender, cholesterol, triglycerides, HDL-C, and LDL-C, the multivariate OR of HOMA-IR abnormality was notably higher for BMI than for body fat content, WC, and systolic BP.
The combined effect on the risk of abnormal HOMA-IR among three risk factors-body fat content, BMI, and systolic BP-is shown in Table 4 . Compared with a reference group that included subjects without any of these three risk factors, those with all risk factors had a significantly higher risk of abnormal HOMA-IR (OR ¼ 101.45; 95% CI ¼ [43.02, 239.24]). Furthermore, participants with one or any combination of two of these three factors had 14.86-or 55.30-fold increased risk for HOMA-IR abnormality over the reference group, respectively. The OR was unaffected by gender. This finding shows a significant combined effect on risk of HOMA-IR abnormality for WC, BMI, and systolic BP among adolescents.
Discussion
Several studies have shown that a transient physiological insulin resistance develops in the pubertal period, although its cause is not fully understood (Kurtoglu et al., 2010) . Nevertheless, researchers have widely accepted the conclusion that obesity is responsible for the recent increases in the prevalence of insulin resistance in children and adults (Cruz et al., 2004; Mills et al., 2004; Van der Aa et al., 2015) . In this regard, there has been an increase in maturity-onset diabetes in obese youth and, because of the transient physiological status of insulin resistance, there is extra stress on the b cells in these youth. Among the obesityrelated factors associated with insulin resistance, WC has been one of the most interesting for diagnostic purposes in children (Esmaillzadeh et al., 2006; Hirschler et al., 2005; Moreno et al., 2002) . However, there is still debate as to whether WC alone can be used to identify adolescents with insulin resistance. Therefore, in the present study, we aimed to determine the level of influence of obesity-related factors on the risk for insulin resistance in order to establish which has the greatest effect in adolescents and to ascertain if a single factor could be used to identify insulin resistance in this population.
Our results reinforce the findings of previous studies (Lin et al., 2015; Reaven, 2004; Rogero Blanco et al., 2012) and are novel in the context of the Spanish population, which furthers the argument for generalizability of the cause of IR. Our findings regarding the individual and collective influence of the factors involved in the development of insulin resistance in our young sample provide information about the individual and collective usefulness of these parameters for assessing the risk of developing MetS. These findings are particularly important because in most other studies on this topic, the sample population comprised adults (Rogero Blanco et al., 2012) .
Our results show that there is a positive association between abnormal HOMA-IR values and the biological/physiological indicators of BMI, body fat content, WC, and systolic BP. As Lin et al. (2015) also highlighted, the close association between these anthropometric variables and BP levels in relation to abnormal HOMA-IR values (i.e., their combined effect) indicates that this relationship should be regarded as a predictive risk factor for insulin resistance. Similar to Reaven's (2004) study, our results show the effects of BMI, body fat percentage, WC, and systolic BP levels, factors that heighten the risk of an abnormal HOMA-IR. In the present study, BMI had the highest predictive value, as assessed by using the OR of HOMA-IR as a determiner compared to WC, body fat (%), and systolic BP. The OR value was highly increased, as we adjusted it for gender and levels of cholesterol, triglycerides, HDL-C, and LDL-C. Our biochemical study revealed that participating youth with an abnormal HOMA-IR level had elevated levels of almost all of the parameters we studied. However, we found no significant correlation between gender and HOMA-IR group (abnormal vs. normal), which was unexpected because previous authors have proposed that girls are more resistant to insulin compared to boys. In a systematic review, Van der Aa, Fazeli Farsani, Knibbe, De Boer, and Van der Vorst (2015) found that 7 of the 13 studies reported sex-specific prevalence rates of insulin resistance. However, the authors pointed out that the reason for this sex difference is unknown because it was not associated with either the pubertal state or adipose tissue content.
High levels of homocysteine, NEFA, and ceruloplasmin are additional risk factors for insulin resistance and for the early development of cardiovascular disorders such as arteriosclerosis, coronary artery blockage, and high BP, as described in previous research (Fridman, D' Eramo, & Finkelstein, 1997; Zulet et al., 2007) . Others have pointed out that homocysteine levels are not a relevant cardiovascular risk factor in adolescents that consume adequate diets (Bindler, Massey, Shultz, Mills, & Short, 2004) . Bindler et al.' s results are in agreement with those of Papandreou, Mavromichalis, Makedou, Rousso, and Arvanitidou (2006) , who explored a similar question in a sample of 524 Greek adolescents. The disparity between the traditional concerns regarding homocysteine and these new observations justifies the continued investigation of the potential influence of homocysteine on cardiovascular risk, especially when there are insufficient reference data in representative samples of adolescent populations (Must, Jacques, Rogers, Rosenberg, & Selhub, 2003) . Likewise, controversy remains regarding the clinical significance of NEFA and ceruloplasmin levels and not only in adolescents. There is widespread acceptance that NEFA can mediate insulin resistance via their release by adipose tissue. However, Karpe, Dickmann, and Frayn (2011) reexamined this concept on the basis of newly available literature and concluded that more emphasis should be placed on alternative explanations for the relationship between obesity and insulin resistance, such as impaired adipose tissue fat storage or dysfunctional regulation of adipokines or adipose-related inflammatory cytokines. We believe that ceruloplasmin should be considered a promising marker for insulin resistance. Ceruloplasmin is released by the liver and is the main copper-carrying protein; as an acute-phase protein, it is also related to systemic inflammation. The associations between ceruloplasmin and factors related to insulin resistance are still controversial. Although researchers have found ceruloplasmin to be independently associated with intra-abdominal fat thickness (Cignarelli et al., 1996) and elevated in subjects with MetS (Kim et al., 2002) , others did not find any kind of association between ceruloplasmin and obesity (Safavi, Ziaei, & Maracy, 2012) . In Spanish adolescents, Wärnberg et al. (2006) found significant correlations between BMI and WC with ceruloplasmin, and, more recently, we reported significant correlations between ceruloplasmin and BMI z-score in nonobese and obese subjects (Aguilar, González-Jiménez, Antelo, & Perona, 2013) . While our data are in agreement with those of some of these authors, it is obvious that there are contradictions that justify the inclusion of these variables in future studies.
Furthermore, the high levels of insulin, HBA1c, total cholesterol, triglycerides, and LDL cholesterol in those youth with abnormal HOMA-IR values in the present study were in close agreement with the results previous researchers have obtained (Park et al., 2012; Pastucha et al., 2013) . Nonetheless, the crosssectional nature of this study limits our ability to detect causal relationships between each of the factors analyzed and the possible development of insulin resistance. In this sense, and as Lin et al. (2015) underlined, future studies should focus on the monitoring and evaluation over time of all the potentially influential factors and circumstances in the genesis of MetS at an early age.
In summary, our findings confirmed anthropometric indicators such as BMI, body fat content, and WC as well as other parameters such as systolic BP and all of the biochemical markers we analyzed as important risk factors for the development of insulin resistance. We found that BMI exerts the greatest influence and that the contributions of any two factors combined are enough to raise the risk 7-fold in terms of OR. These markers could also play an important role in later development of MetS, T2DM, and cardiovascular diseases. Nurses could, thus, use simple anthropometric measures and biochemical analyses to identify children and adolescents at risk of developing insulin resistance, which could be extremely useful for preventing diseases related to MetS in adulthood.
